Kite and Arcellx Announce Strategic Collaboration to Co-develop and Co-commercialize Late-stage Clinical CART-ddBCMA in Multiple Myeloma Nia JulianDecember 12, 2022 Facebook0 Twitter Pinterest0 0 Likes
